Evidence map›Paper›PMID 37260473›Full record

ArticleJournal of applied statistics2023

On diagnostic accuracy measure with cut-points criterion for ordinal disease classification based on concordance and discordance.

Jing Kersey, Hani Samawi, Jingjing Yin, Haresh Rochani, Xinyan Zhang

Abstract read
In one paragraph

Article in Journal of applied statistics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jing KerseyDepartment of Biostatistics, Epidemiology and Environmental Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro.ORCID https://orcid.org/0000-0001-7256-3978
Hani SamawiDepartment of Biostatistics, Epidemiology and Environmental Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro.
Jingjing YinDepartment of Biostatistics, Epidemiology and Environmental Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro.ORCID https://orcid.org/0000-0003-4843-613X
Haresh RochaniDepartment of Biostatistics, Epidemiology and Environmental Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro.
Xinyan ZhangDepartment of Biostatistics, Epidemiology and Environmental Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accuracy of a diagnostic test has always been essential in detecting disease staging. Many diagnostic tests of accuracy measures are used in binary diagnosis tests. Some measures apply to multi-stage diagnosis. Yet, there are limitations to the implementation, and the performance highly depends on the distribution of diagnostic outcomes. Another essential aspect of medical diagnostic testing using biomarkers is to find an optimal cut-point that categorizes a patient as diseased or healthy. This aspect was extended to the diseases with more than two stages. We propose a diagnostic accuracy measure and optimal cut-points selection (CD), using concordance and discordance for k-stages diseases. The CD measure uses the classification agreement and disagreement between tests outcomes and diseases stages. Simulations for power studies suggest that CD can detect the differences between the null and alternative hypotheses that other methods cannot for some scenarios. Simulation results indicate that using CD measures to select optimal cut-points can provide relatively high correct classification rates than the existing measures and more balanced accurate classification rates than the generalized Youden Index (GYI). An illustration is provided using the ANDI data to choose biomarkers for diagnosing Alzheimer's Disease (AD) and select optimal cut-points for the chosen biomarkers.

Indexed as

Alzheimer's Disease (AD)concordance and discordancecut-point selectiondiagnostic accuracyDiagnostic testk-stage diseases

Identifiers

PMID37260473
PMCPMC10228310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.